B细胞淋巴瘤-话题@MedSci

#B细胞淋巴瘤#

2篇内容 | 2377人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2272800, encodeId=e0b522e280032, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=2acd40e7ba' target=_blank style='color:#2F92EE;'>#Car-T细胞疗法#</a>, objectTitle=【Blood Adv】双抗与CAR-T治疗B细胞淋巴瘤时的感染对比：一项系统回顾和Meta分析, objectType=article, longId=886009, objectId=b2d588600986, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220719/1658202183571_5552845.jpg, objectUrl=/article/show_article.do?id=b2d588600986, replyNumber=0, likeNumber=15, createdTime=2025-07-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b2d588600986, moduleTitle=【Blood Adv】双抗与CAR-T治疗B细胞淋巴瘤时的感染对比：一项系统回顾和Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2d588600986)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2271434, encodeId=ee6522e1434ef, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=1bf011141e3e' target=_blank style='color:#2F92EE;'>#塞利尼索#</a>, objectTitle=【Cancer Sci】塞利尼索可协同CD19 CAR-T治疗B细胞淋巴瘤, objectType=article, longId=884592, objectId=aa42884592fc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220813/1660373278819_8252897.webp, objectUrl=/article/show_article.do?id=aa42884592fc, replyNumber=0, likeNumber=27, createdTime=2025-06-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=aa42884592fc, moduleTitle=【Cancer Sci】塞利尼索可协同CD19 CAR-T治疗B细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa42884592fc)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2266731, encodeId=0e782266e315b, content=<a href='/topic/show?id=4e2640e283' target=_blank style='color:#2F92EE;'>#CAR-T细胞#</a> <a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=8e9d119883d8' target=_blank style='color:#2F92EE;'>#IL18#</a>, objectTitle=NEJM：新临床研究表明一种下一代“装甲”，CAR-T细胞疗法有望更有效治疗淋巴瘤, objectType=article, longId=879091, objectId=e6c38e9091dc, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/bioon-com/20250526/1748212087713_2185383.png, objectUrl=/article/show_article.do?id=e6c38e9091dc, replyNumber=0, likeNumber=13, createdTime=2025-05-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=0, avatar=, status=0, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=null, followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2262731, encodeId=3cc82262e315b, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a>, objectTitle=弥漫性大B细胞淋巴瘤分期, objectType=article, longId=874049, objectId=5fc28e40498e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250219/1739927168693_8538692.jpg, objectUrl=/article/show_article.do?id=5fc28e40498e, replyNumber=0, likeNumber=9, createdTime=2025-04-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5fc28e40498e, moduleTitle=弥漫性大B细胞淋巴瘤分期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fc28e40498e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2261904, encodeId=d81f226190400, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>, objectTitle=【Blood Adv】CAR-T治疗高危B细胞淋巴瘤，放疗桥接可行, objectType=article, longId=873344, objectId=b21f8e3344c0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250205/1738742488792_8538692.jpg, objectUrl=/article/show_article.do?id=b21f8e3344c0, replyNumber=0, likeNumber=35, createdTime=2025-04-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=b21f8e3344c0, moduleTitle=【Blood Adv】CAR-T治疗高危B细胞淋巴瘤，放疗桥接可行, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b21f8e3344c0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2244827, encodeId=0cfb224482e54, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=567650039e9' target=_blank style='color:#2F92EE;'>#弥漫大B细胞淋巴瘤#</a>, objectTitle=指南更新 | B细胞淋巴瘤NCCN（2025.V1）：新增Glofit-GemOx、Mosun-Pola方案二线治疗DLBCL！, objectType=article, longId=856198, objectId=9bbf85619893, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241224/1735002622514_8538692.jpg, objectUrl=/article/show_article.do?id=9bbf85619893, replyNumber=0, likeNumber=60, createdTime=2024-12-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=9bbf85619893, moduleTitle=指南更新 | B细胞淋巴瘤NCCN（2025.V1）：新增Glofit-GemOx、Mosun-Pola方案二线治疗DLBCL！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bbf85619893)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224197, encodeId=cb7d222419e41, content=<a href='/topic/show?id=dd85431162e' target=_blank style='color:#2F92EE;'>#多发性骨髓瘤#</a> <a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=edba4069ec' target=_blank style='color:#2F92EE;'>#CAR-T治疗#</a>, objectTitle=【Nat Med】专家观点：感染是CAR-T治疗后非复发死亡的主要驱动因素, objectType=article, longId=841816, objectId=b97884181669, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720670560286_5579292.jpg, objectUrl=/article/show_article.do?id=b97884181669, replyNumber=0, likeNumber=91, createdTime=2024-09-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b97884181669, moduleTitle=【Nat Med】专家观点：感染是CAR-T治疗后非复发死亡的主要驱动因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b97884181669)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2195485, encodeId=71c12195485f1, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=331e8e782fd' target=_blank style='color:#2F92EE;'>#药物治疗#</a>, objectTitle=指南解读 | B细胞淋巴瘤NCCN（2024.V1）：多个亚型新增治疗方案！, objectType=article, longId=816161, objectId=70b9816161e9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-team-discussing-together-in-the-hallway-PJWSSDB.jpg, objectUrl=/article/show_article.do?id=70b9816161e9, replyNumber=0, likeNumber=115, createdTime=2024-03-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=70b9816161e9, moduleTitle=指南解读 | B细胞淋巴瘤NCCN（2024.V1）：多个亚型新增治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70b9816161e9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2183333, encodeId=f656218333386, content=<a href='/topic/show?id=c14d5638971' target=_blank style='color:#2F92EE;'>#指南#</a> <a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a>, objectTitle=指南更新 | B细胞淋巴瘤NCCN指南（2024.V1）更新！, objectType=article, longId=807143, objectId=03c480e143c2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-at-work-PGMH47J.jpg, objectUrl=/article/show_article.do?id=03c480e143c2, replyNumber=0, likeNumber=183, createdTime=2024-01-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=03c480e143c2, moduleTitle=指南更新 | B细胞淋巴瘤NCCN指南（2024.V1）更新！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03c480e143c2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2181855, encodeId=db09218185544, content=<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=edba4069ec' target=_blank style='color:#2F92EE;'>#CAR-T治疗#</a>, objectTitle=【AJH】优化CAR-T治疗安全性：B细胞淋巴瘤CAR-T治疗中病毒感染预防和治疗, objectType=article, longId=809353, objectId=75898093532a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/prescription-form-with-medical-stethoscope-9ZRKVHM.jpg, objectUrl=/article/show_article.do?id=75898093532a, replyNumber=0, likeNumber=113, createdTime=2024-01-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=75898093532a, moduleTitle=【AJH】优化CAR-T治疗安全性：B细胞淋巴瘤CAR-T治疗中病毒感染预防和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75898093532a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2170707, encodeId=1e7e21e0707d6, content=<a href='/topic/show?id=5eae41e7007' target=_blank style='color:#2F92EE;'>#基因检测#</a> <a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a> <a href='/topic/show?id=5bd36658e94' target=_blank style='color:#2F92EE;'>#滤泡性淋巴瘤#</a> <a href='/topic/show?id=ab2023868f8' target=_blank style='color:#2F92EE;'>#二代测序#</a>, objectTitle=刨根问底，滤泡性淋巴瘤指南推荐的这些基因检测有何意义？, objectType=article, longId=802091, objectId=ad4a80209151, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-staff-meeting-GXNVP9J.jpg, objectUrl=/article/show_article.do?id=ad4a80209151, replyNumber=0, likeNumber=182, createdTime=2023-11-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=ad4a80209151, moduleTitle=刨根问底，滤泡性淋巴瘤指南推荐的这些基因检测有何意义？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ad4a80209151)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2143256, encodeId=e5ec2143256a5, content=<a href='/topic/show?id=70d3499e550' target=_blank style='color:#2F92EE;'>#张毅#</a>教授：6个月CR达67%！双靶点<a href='/topic/show?id=36ab1063421f' target=_blank style='color:#2F92EE;'>#FasTCAR-T细胞治疗#</a>复发/难治性<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a>结果亮相EHA！张毅是<a href='/topic/show?id=0d3240e64e' target=_blank style='color:#2F92EE;'>#CAR-T细胞治疗#</a>领域的著名教授, objectTitle=EHA 2023 | 张毅教授：6个月CR达67%！双靶点FasTCAR-T细胞治疗复发/难治性B细胞淋巴瘤结果亮相EHA！, objectType=article, longId=777227, objectId=fae9e77227ab, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230603/d5fcbd91f26247229f8895b192c64965.jpg, objectUrl=/article/show_article.do?id=fae9e77227ab, replyNumber=0, likeNumber=152, createdTime=2023-06-17, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fae9e77227ab, moduleTitle=EHA 2023 | 张毅教授：6个月CR达67%！双靶点FasTCAR-T细胞治疗复发/难治性B细胞淋巴瘤结果亮相EHA！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fae9e77227ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241574, encodeId=c79112415e49e, content=<a href='/topic/show?id=b2434060d8' target=_blank style='color:#2F92EE;'>#CAR-NK#</a>用于复发/难治性<a href='/topic/show?id=8fe738515a' target=_blank style='color:#2F92EE;'>#B细胞淋巴瘤#</a><a href='/topic/show?id=8dcd12852f1' target=_blank style='color:#2F92EE;'>#NK细胞#</a>, objectTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, objectType=article, longId=725533, objectId=55e3e255332a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220424/0488d69902dd4699ae7d7d9b2b7c5eef.jpg, objectUrl=/article/show_article.do?id=55e3e255332a, replyNumber=0, likeNumber=158, createdTime=2022-08-28, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55e3e255332a, moduleTitle=通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55e3e255332a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

B细胞淋巴瘤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #Car-T细胞疗法#

【Blood Adv】双抗与CAR-T治疗B细胞淋巴瘤时的感染对比：一项系统回顾和Meta分析

2025-07-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #塞利尼索#

【Cancer Sci】塞利尼索可协同CD19 CAR-T治疗B细胞淋巴瘤

2025-06-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#CAR-T细胞# #B细胞淋巴瘤# #IL18#

2025-05-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤#

弥漫性大B细胞淋巴瘤分期

2025-04-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #CAR-T细胞治疗#

【Blood Adv】CAR-T治疗高危B细胞淋巴瘤，放疗桥接可行

2025-04-24发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #弥漫大B细胞淋巴瘤#

指南更新 | B细胞淋巴瘤NCCN（2025.V1）：新增Glofit-GemOx、Mosun-Pola方案二线治疗DLBCL！

2024-12-25发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#多发性骨髓瘤# #B细胞淋巴瘤# #CAR-T治疗#

【Nat Med】专家观点：感染是CAR-T治疗后非复发死亡的主要驱动因素

2024-09-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #药物治疗#

指南解读 | B细胞淋巴瘤NCCN（2024.V1）：多个亚型新增治疗方案！

2024-03-26发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#指南# #B细胞淋巴瘤#

指南更新 | B细胞淋巴瘤NCCN指南（2024.V1）更新！

2024-01-23发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#B细胞淋巴瘤# #CAR-T治疗#

【AJH】优化CAR-T治疗安全性：B细胞淋巴瘤CAR-T治疗中病毒感染预防和治疗

2024-01-15发表于陕西省

梅斯管理员 (审核中...)

前往app查看评论内容

#基因检测# #B细胞淋巴瘤# #滤泡性淋巴瘤# #二代测序#

刨根问底，滤泡性淋巴瘤指南推荐的这些基因检测有何意义？

2023-11-24发表于陕西省

侠胆医心 (审核中...)

前往app查看评论内容

#张毅#教授：6个月CR达67%！双靶点#FasTCAR-T细胞治疗#复发/难治性#B细胞淋巴瘤#结果亮相EHA！张毅是#CAR-T细胞治疗#领域的著名教授

EHA 2023 | 张毅教授：6个月CR达67%！双靶点FasTCAR-T细胞治疗复发/难治性B细胞淋巴瘤结果亮相EHA！

2023-06-17发表于上海

循证小兵 (审核中...)

前往app查看评论内容

#CAR-NK#用于复发/难治性#B细胞淋巴瘤##NK细胞#

通用型CAR-NK用于复发/难治性B细胞淋巴瘤，3/6例获得CR

2022-08-28

科室
- - 订阅+
  - 更多科室
工具
服务